Pharmaceutical Companies Poised to Build Infrastructure to Accommodate Real World Evidence, According to the Tufts Center for the Study of Drug Development https://t.co/miMYJBkB9x
— The Propell Group (@ThePropellGroup) December 28, 2017
Pharmaceutical Companies Poised to Build Infrastructure to Accommodate Real World Evidence, According to the Tufts Center for the Study of Drug Development https://t.co/miMYJBkB9x
— The Propell Group (@ThePropellGroup) December 28, 2017